The United States is a leading market for cryostat microbiome equipment, supported by substantial investments in biomedical research, advanced healthcare infrastructure, and a strong presence of biotechnology and pharmaceutical companies. Growing focus on microbiome studies, precision medicine, and molecular diagnostics is driving demand for high-performance laboratory equipment. Additionally,...